Keyword
Quick search:
Content Search
Result Content Research
Result Content Research
1 How Emergent BioSolutions Earned Profits But Delivered Disappointing Vaccine Returns
2 FDA Clears 10M Johnson & Johnson COVID Vaccine Doses From Baltimore’s Emergent BioSolutions
3 Some Covid vaccine made by Emergent BioSolutions to be distributed, while much will be discarded
4 UPDATED DEADLINE MONDAY: ROSEN, SKILLED INVESTOR COUNSEL, Reminds Emergent BioSolutions Inc. Investors With Losses Over $100K of the Updated June 21 Deadline in Securities Class Action Due to the Recently Declared Federal Court Holid
5 House lawmakers grill Emergent BioSolutions executives at hearing
6 EBS UPDATED DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Informs Emergent BioSolutions Inc. Investors of the Updated June 21 Deadline in Securities Class Action Due to the Recently Declared Federal Court Holiday – EBS
7 Emergent BioSolutions Poised To Receive FDA Nod to Restart J&J COVID-19 Shot Production at Baltimore Plant After Mishap: WSJ
8 Two Days Left to Actively Participate in Emergent BioSolutions Inc. (EBS) Class Action: Bronstein, Gewirtz & Grossman, LLC
9 Final Deadline for Investors to Actively Participate in Emergent BioSolutions Inc. (EBS) Class Action: Bronstein, Gewirtz & Grossman, LLC
10 Emergent BioSolutions, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit
11 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Emergent BioSolutions Inc.
12 Emergent Biosolutions Inc (EBS) falls -4.0720% for June 18
13 Emergent BioSolutions Stock News: Berger Montague Announces Investigation Into Securities Fraud Allegations Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021
14 Biden admin probes risk of low-level contamination in vaccines made at troubled plant
15 Entwistle & Cappucci LLP Announces It Has Filed a Securities Class Action Against Emergent BioSolutions Inc. (NYSE: EBS)
16 The Emergent BioSolutions (NYSE:EBS) Share Price Has Gained 37% And Shareholders Are Hoping For More
17 Emergent BioSolutions: Value And Fear Go Hand In Hand
18 HAGENS BERMAN Encourages Emergent BioSolutions (EBS)
19 Who Has Been Selling Emergent BioSolutions Inc. (NYSE:EBS) Shares?
20 Last Few Days to Actively Participate in Emergent BioSolutions Inc. (EBS) Class Action: Bronstein, Gewirtz & Grossman, LLC
21 EMERGENT BIOSOLUTIONS 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Emergent BioSolutions Inc.
22 Emergent BioSolutions Announces Positive Two-Year Persistence Data From Phase 2 Study Evaluating CHIKV VLP, the
23 EMERGENT BIOSOLUTIONS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Emergent Bio
24 Emergent Biosolutions
25 J&J working with but not dependent on Emergent
26 Is Now The Time To Put Emergent BioSolutions (NYSE:EBS) On Your Watchlist?
27 EMERGENT BIOSOLUTIONS 48 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Emergent BioSolutions Inc.
28 Deadline Approaching for Emergent BioSolutions Investors: Berger Montague Reminds Investors of Approaching Deadline in Securities Fraud Class Action Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021
29 Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for Emergent BioSolutions Inc. Investors – EBS
30 Three More Batches Of Vaccine Approved From Emergent Biosolutions
31 EBS 11-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now, June 18th Deadline Approaching in Securities Fraud Lawsuit
32 FINAL FRIDAY DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors with LARGE LOSSES to Secure Counsel Before Important June 18 Deadline in Securities Class Action
33 DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
34 J&J homes in on manufacturing restart at Emergent plant behind 15M discarded COVID-19 doses
35 Short Interest in Emergent BioSolutions Inc. (NYSE:EBS) Decreases By 14.6%
36 EBS 2-WEEK DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now, June 18th Deadline Approaching in Securities Fraud Lawsuit
37 Emergent Biosolutions Inc (EBS) Stock Loses -6.08% This Week; Should You Buy?
38 Emergent BioSolutions Reaped Millions in Federal Contracts But Has Yet to Deliver Any COVID Vaccines
39 Emergent BioSolutions Stock Shows Every Sign Of Being Significantly Undervalued
40 Production plant put millions of vaccines into question, as US promises to send them abroad
41 EBS 3-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now
42 CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Emergent BioSolutions Inc. Shareholders of Securities Fraud Class Action Lawsuit
43 EBS 2-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors with Losses to Contact the Firm Before June 18th Deadline
44 Emergent Biosolutions
45 EBS 4-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now, June 18th Deadline Approaching in Securities Fraud Lawsuit
46 The manufacturing hold at Emergent's Baltimore Bayview plant could be coming to an end — report
47 EBS 10-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now
48 U.S. Is Working to Send Doses Abroad by Replacing AstraZeneca Shots With Others
49 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important June 18 Deadline in Securities Class Action
50 EBS 6-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Before June 18th Deadline in Securities Fraud Action
51 EBS FINAL DEADLINE NOTICE: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Emergent BioSolutions Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 18 Deadline in Securities Class Action
52 INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Emergent BioSolutions Inc.
53 EBS 8-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now
54 ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED LAW FIRM, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EBS
55 INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Class Action Lawsuit Against
56 Final Deadline Approaching on June 18, 2021: Kessler Topaz Meltzer & Check, LLP Reminds Emergent BioSolutions Inc. Investors of Class Action Lawsuit Deadline
57 Emergent BioSolutions Inc. (NYSE:EBS) Director Sells $177,290.72 in Stock
58 EBS Stock News: Berger Montague Investigates Alleged Securities Fraud Claims Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021
59 Pharma Giant Made Record Profits as It Botched COVID-19 Vax Doses: NYT
60 EBS 7-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now, June 18th Deadline Approaching in Securities Fraud Lawsuit
61 High Hopes for Johnson & Johnson’s Covid Vaccine Have Fizzled in the U.S.
62 Emergent Biosolutions Inc (EBS) gains 0.6330% for June 16
63 SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021
64 EBS INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.
65 Workers failed to shower, change clothes at plant with botched J&J doses: report
66 Emergent BioSolutions officials pressed on vaccine production issues during congressional hearing
67 DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Emergent BioSolutions, Inc. and Encourages Investors to Contact the Firm
68 EBS Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Emergent BioSolutions Inc. of Deadline in Securities Fraud Class Action Lawsuit
69 Emergent BioSolutions Inc. (EBS) stock soars during pre-market session. Here’s what’s happening?
70 J&J vaccine production could restart soon
71 Emergent Biosolutions Inc (EBS) falls -2.4130% for June 08
72 Human Combination Vaccines Market Share by Manufacturer (Dynavax Technologies., Emergent BioSolutions Inc., GlaxoSmithKline plc., Merck and Co., Inc.) – COVID-19 Impact and Global Analysis By Type (Live Attenuated Vaccines, Inactivated Vaccines),
73 Emergent BioSolutions, Inc. Investor: Actively participate in the last few days of the class action; Port Noy Law Firm
74 Problematic vaccine plant still lacks approval after some doses cleared
75 Some J&J vaccine doses can be used, but many must be tossed
76 EBS LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Emergent Biosolutions Inc.
77 Troubled Maryland Plant Told To Toss Part Of The J&J Vaccine Ingredient It Manufactured
78 In wake of Emergent BioSolutions' vaccine problems, CEO's stock trades come into focus
79 FDA Preparing To Clear 10M Johnson & Johnson COVID Vaccine Doses From Baltimore's Emergent BioSolutions
80 Emergent BioSolutions' plant behind the lost J&J vaccine batch hit with several FDA red flags last year: report
81 Investor deadline notice: Kessler Topaz Meltzer & Check, LLP reminds investors of the securities fraud class action filed against Emergent BioSolutions Inc. (EBS)
82 Is The Worst Over For Emergent Biosolutions Stock?
83 Emergent BioSolutions halts operations at its Baltimore plant, where J.&J. doses were ruined, at the F.D.A.’s request.
84 FRIDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
85 Emergent Biosolutions Stock Takes A Hit From Vaccine Mix-Up At Baltimore Plant
86 Friday Morning Headlines: Marilyn Mosby flashes middle finger at Keith Davis Jr. supporter; Emergent BioSolutions gave bonuses to top executives; and more
87 Emergent BioSolutions Inc. (NYSE:EBS) Given Average Rating of "Buy" by Brokerages
88 Africa CDC says FDA announcement on J&J issues imminent
89 Emergent BioSolutions agrees to pause Covid-19 vaccine manufacturing at Baltimore facility
90 Lyophilized products are on the rise: Here's what you need to know
91 Emergent BioSolutions says it can make 1 billion Covid vaccine doses annually
92 A brief timeline of Emergent BioSolutions' Baltimore presence
93 Report: Emergent BioSolutions facility responsible for vaccine snafu has history of flouting rules
94 Pay for CEO of Emergent BioSolutions, maker of COVID vaccine in Baltimore, increased 51% in 2020
95 SHAREHOLDER ALERT: EBS ARRY PRVB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
96 The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, EBS and FREQ
97 Emergent Biosolutions Seeks New Talent to Support Global COVID-19 Vaccination Push, Expanding Project Portfolio · BioBuzz
98 Is There Any Hope Left for Emergent BioSolutions?
99 Emergent BioSolutions: Top Official Warned That Vaccine Plant Had to Be 'Monitored Closely`
100 How Emergent BioSolutions Put an ‘Extraordinary Burden’ on the U.S.’s Troubled Stockpile